MedTrace Logo

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients

NCT00786032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2015-01-08

Study results available
· View outcomes & findings →

Summary

The goal of this VA demonstration project is to show that the Brain-computer interface (BCI) technology is a clinically practical and important new communication and control option that can improve the lives of veterans with amyotrophic lateral sclerosis (ALS). The project will test four well-supported hypotheses: (1) that people with ALS who find (or will soon find) conventional assistive technology inadequate can and will use a BCI system for important purposes in their daily lives without close technical oversight, 2) they will continue and even increase this use throughout the period of the study, (3) that BCI use will improve their lives, and 4) BCI will improve the lives of their families and caregivers.

Conditions

  • ALS (Amyotrophic Lateral Sclerosis)

Interventions

DEVICE

BCI Device

A Brain Computer interface or BCI records brain signals and analyzes them to derive device commands. BCIs give their users communication and control channels that do not depend on peripheral nerves and muscles.

Sponsors & Collaborators

Principal Investigators

  • Robert Ruff, MD PhD · VA Medical Center-Cleveland

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-06-30
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00786032 on ClinicalTrials.gov